Perspective Therapeutics (CATX) Return on Capital Employed Growth (5y) (2016 - 2026)
Perspective Therapeutics (CATX) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86,346.00 |
| Mar 31, 2026 | 103,475.00 |
| Dec 31, 2025 | 128,508.00 |
| Sep 30, 2025 | 977.00 |
| Jun 30, 2025 | 1,361.00 |
| Mar 31, 2025 | 1,672.00 |
| Dec 31, 2024 | 2,329.00 |
| Sep 30, 2024 | 4,042.00 |
| Jun 30, 2024 | 4,402.00 |
| Mar 31, 2024 | 4,007.00 |
| Dec 31, 2023 | 1,434.00 |
| Sep 30, 2023 | 4,387.00 |
| Jun 30, 2023 | 8,269.00 |
| Mar 31, 2023 | 4,954.00 |
| Dec 31, 2022 | 3,680.00 |
| Sep 30, 2022 | 3,625.00 |
| Jun 30, 2022 | 3,865.00 |
| Mar 31, 2022 | 3,668.00 |
| Dec 31, 2021 | 3,262.00 |
| Sep 30, 2021 | 3,042.00 |